GlaxoSmithKline

Q2 results 2014

23 Jul 2014

Healthcare group says Q2 results reflect a business facing currency headwinds, increased price competition and supply disruptions to its Consumer business. The company says that the strategic investments its making long term will reap dividends. Interview with CEO Sir Andrew Witty and CFO Simon Dingemans.